|
|
|
Usually respond well but often recur
|
Nasal squamous cell carcinoma
|
|
Response is often minimal
|
|
|
|
Some subtypes respond better than others
|
|
|
|
Response may be better if after surgery
|
|
|
|
Poor response usually unless after surgery
|
Oral squamous cell carcinoma
|
|
Especially poor in cats; aggressive treatment required
|
|
|
|
Metastatic disease in >90%; pain palliation
|
|
|
|
Best when small; metastasis a problem
|
|
|
|
Depends on tissue of origin
|
Injection-related fibrosarcoma
|
|
Best if done after first surgery, poor later
|
|
|
|
Usually respond very well; 131I possible
|
|
|
|
Treat with 131I (>95% cure)
|
|
|
|
Usually respond well, especially in cats
|
|
|
|
Usually stabilizes mass; good clinical result
|
|
|
|
Depends on size, location, and clinical signs
|
|
|
|
Most effective treatment for CNS lymphoma
|
|
|
|
Effective but short term due to other disease
|
Spinal cord mesenchymal tumor
|
|
Reasonable response but dose limited by cord
|
|
|
|
Short-term response good but commonly recur
|
|
|
|
Excellent response but can only treat locally
|
|
|
|
|
|
|
|
Good response, often very durable
|
|
|
|
Low for scirrhous form, high for lymphocytic
|
|
|
|
Large masses, dose limited by heart and lungs
|
|
|
|
Difficult to accurately localize treatment
|
Transitional cell carcinoma
|
|
May respond well initially but recur
|
|
|
|
Data available on response is quite variable
|
|
|
|
Very good for low grade, less for high grade
|
Peripheral nerve sheath tumor
|
|
Strongly recommended after surgery
|
|
|
|
Improves control after surgery, not alone
|
Apocrine gland anal sac adenocarcinoma
|
|
Usually treat regional lymph nodes as well
|
|
|
|
|
|
|
|
Treatment of last resort, often works well
|
Transmissible venereal tumor
|
|
Very good control even for large tumors
|
|
|
|
Used in refractory tumors, brachytherapy
|
|
|
|
Beam treatment effective, very few sites
|
Equine ocular squamous cell carcinoma
|
|
Best treatment when bone involved
|
